Ratkaistu EU-hankintaKorjattu 28.9.2023

Potassium iodide 130 mg and 65 mg / 2023-2024

Finnish Institue for Health and Welfare · alue ei tiedossa

Perustiedot

Tarjousten määräaika
ma 30.10.2023 klo 12.00 (päättynyt)
Kysymysten määräaika
ma 16.10.2023 klo 12.00 (päättynyt)
Hankkija
Finnish Institue for Health and Welfare, Y-tunnus 2229500-6
Toteutuspaikka
alue ei tiedossa
Hankintalaji
Tavarahankinta
Menettely
Avoin menettely, EU-hankinta
Ilmoituksen tyyppi
Hankintailmoitus
Arvioitu kokonaisarvo
Ei ilmoitettu
Erät
2 erää
Pääasiallinen CPV
33695000 Kaikki muut ei-terapeuttiset valmisteet
Lisäkoodit: 33600000
Sopimuskausi
11 kuukautta
Julkaistu
28.9.2023
Muutosilmoitus: Ostajan virheen korjaaminen

Ilmoituksen teksti

Alkuperäinen teksti Hilmasta, muuttamattomana
Finnish Institute for Health and Welfare, later referred to as THL, request your tender for Potassium iodide 130 mg and 65 mg to the rescEU project. The Scope of procurement is described in more detail in Annex 1. The procurement is divided in two (2) lots. Tender may be submitted for one or several lots. LOT 1: Potassium iodide 130 mg LOT 2: Potassium iodide 65 mg The minimum requirements for the articles is described in Annexes 1.1 and 1.2. The contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The contract period shall enter into force once the contract has been signed by contracting parties and expires when all contractual duties of the contract have been performed. Estimated quantity for the product in described in Annex 5 (restricted, TLIV). Please note that all times given in the Call for Tender refer to local time in Finland. Call for Tenders, Annexes: Annex 1 Scope of the procurement Annex 1.1 Minimum requirements for lot 1 Annex 1.2 Minimum requirements for lot 2 Annex 2 Contract Annex 3 Description of the Handi service Annex 4 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 5 Estimated quantity (restricted, TLIV) Annex 6 Confidentiality commitment Please note that the numbering of the annexes differs between the Contract and the Call for Tenders.

Lisätiedot

The availability for the Annex 5 is restricted. THL will send the restricted Annex 5 to a representative of the tenderer via encrypted email after THL has received the signed confidentiality commitment (Annex 6). Confidentiality commitment shall be signed in person for each person handling Annex 5. Confidentiality commitment shall be sent to the email address kirjaamo@thl.fi with the subject line "CONFIDENTIALITY COMMITMENT - THL/4526/2.02.06/2023 / Potassium iodide 130 mg and 65 mg / 2023-2024". The message must contain name of the tenderer and email address to which the restricted Annex 5 is to be sent.

Muutoksen syy

The Call for Tenders had to be placed in a correction mode, as an additional annex was attached to the Call for Tenders. Due to the resulting delay, the deadlines for receiving tenders and for receiving questions were extended.

Erien kuvaukset

Erä 1: LOT 1: Potassium iodide 130 mg
The subject of the procurement is article in accordance with the following requirements: - The subject of tender: “Potassium iodide 130 mg” - Active pharmaceutical ingredient: Potassium iodide - Pharmaceutical form: tablets - Package size: 10 - 100 tablets in blisters or in bottles. The minimum requirements of the article is described in more detail in Annex 1.1. The article can be offered in a strength of 130 mg tablet or, alternatively, twice that amount in a strength of 65 mg tablets. Estimated quantity for the article is described in Annex 5 (restricted, TLIV). The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Erä 2: LOT 2: Potassium iodide 65 mg
The subject of the procurement is article in accordance with the following requirements: - The subject of tender: “Potassium iodide 65 mg” - Active pharmaceutical ingredient: Potassium iodide - Pharmaceutical form: tablets - Package size: 10 - 100 tablets in blisters or in bottles. The minimum requirements of the article is described in more detail in Annex 1.2. Estimated quantity for the article is described in Annex 5 (restricted, TLIV). The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.

Erät

Erä Nimi Ammattiala Arvioitu arvo CPV
1 LOT 1: Potassium iodide 130 mg Ratkaistu – – 33695000, 33600000
2 LOT 2: Potassium iodide 65 mg Ratkaistu – – 33695000, 33600000

Hankinnan vaiheet

  1. –Hankintailmoitus

    Aiempi versio. Sen tiedot eivät ole Urakkahaussa.

  2. Muutosilmoitustämä ilmoitus

    Ostajan virheen korjaaminen.

  3. Jälki-ilmoitus

    Voittaja: G.L. Pharma Nordic AB.

Lähde: Hilma (hankintailmoitukset.fi)

Ilmoitus 2023-000370

Ilmoita virheestä tai pyydä poistoa